"Account-based" has been stretched to mean almost anything — a software category, an ad-targeting setting, a campaign type. In life sciences, where the buying group is small, technical, and slow to trust, it means something far more specific.
What does account-based actually mean?
It means the account, not the lead, is the unit of work. You stop measuring activity by how many individuals you reached and start measuring it by how well you understand and serve a defined set of organizations. Everything — research, messaging, sequencing, follow-up — orients around the account as a whole.
Why does this matter more in life sciences?
Because decisions here are made by committees, not individuals. A scientist, a procurement lead, and a commercial sponsor may all touch the same purchase, on different timelines, with different concerns. Treating any one of them as "the lead" misreads the room. Account-based thinking accepts the committee as the reality and builds around it.
Is account-based a tool or a discipline?
A discipline. Tools can help you execute it, but no platform makes you account-based — only a decision about focus does. The hard part is saying no: choosing a defensible set of accounts you can genuinely serve, and resisting the pull to spray effort across everyone who might someday buy.
How do you put it into practice?
Start narrow. Build real knowledge of each chosen account — who is involved, what they care about, where they are on Like, Trust, Habit. Then sequence touches that move the whole account forward, not just one contact. This is the backbone of account-based marketing for life sciences: fewer targets, deeper understanding, and patience matched to how these organizations actually decide.
Done well, account-based stops being a marketing tactic and becomes the operating logic of the whole commercial effort — a way of concentrating limited attention where it can compound.